Impact of pharmaceutical care interventions in improving clinical outcomes among patients with pulmonary tuberculosis: a systematic review.
Kheloud AwadMyriam JaamAhmed AwaisuDerek StewartHassaan Anwer RathoreMuhammad Abdul HadiPublished in: Journal of pharmaceutical policy and practice (2024)
The current evidence suggests that pharmaceutical care interventions can potentially improve treatment outcomes among patients with pulmonary TB. However, no definitive conclusion can be drawn given the low methodological quality of the included studies and lack of long-term follow-up data. Well-designed RCTs with careful attention to study methodology, standardised outcomes assessment aligned with the World Health Organization's guidelines are warranted to guide future practice and policy.
Keyphrases
- healthcare
- pulmonary tuberculosis
- quality improvement
- mycobacterium tuberculosis
- palliative care
- physical activity
- primary care
- pulmonary hypertension
- working memory
- mental health
- affordable care act
- electronic health record
- metabolic syndrome
- pain management
- type diabetes
- clinical practice
- big data
- current status
- squamous cell carcinoma
- radiation therapy
- chronic pain
- case control